Smiling caregiver supporting senior woman in walking.

Thanks to a recent partnership, Humana members in New York will soon be able to access innovative home care services through East Coast-based home care provider CINQCARE.

The provider currently operates in nine locations across the United States, offering clients with home health, personal care, transportation and nutrition services, on-call health counseling, patient monitoring and more.

“Our partnership with Humana represents a pivotal moment in our ongoing dedication to deliver care that treats members like family,” Rodney Armstead, MD, CINQCARE’s chief medical officer, said in a statement. “Humana and CINQCARE will work to create a positive and enduring impact on improving health, care and well-being in the homes and communities of those who need it most.”

Humana’s qualifying members will receive services through CINQCARE’s Care at Home model, which offers care management, round-the-clock telehealth support, remote patient monitoring and home visits. CINQCARE is also an Accountable Care Organization in the Realizing Equity, Access, and Community Health (REACH) model. The company’s aim is to promote better health outcomes for marginalized groups, especially Black and Brown communities, through comprehensive in-home care, according to a release.

“By combining our expertise and resources, Humana and CINQCARE hope to make significant strides in improving the health and well-being of the diverse population of Medicare Advantage members we serve in New York,” Julie Mascari, Humana’s Medicare president for the northeast region, said in a statement. “Our unwavering commitment has always been to provide high-quality care and improve health outcomes.”

Humana has made other news this week. It reportedly recently has begun talks with Cigna about a potential stock-and-cash merger between the two insurers. Cigna is looking to sell off its Medicare Advantage business, according to investment analysis firm Seeking Alpha, as it currently controls only about 2% of the market. Humana, meanwhile, controls a much larger share of the MA market, though experts expect that the transaction is likely to prompt antitrust enforcement action and may take up to a year or longer to reach its close.